Literature DB >> 11342298

Pax5 determines the identity of B cells from the beginning to the end of B-lymphopoiesis.

S L Nutt1, D Eberhard, M Horcher, A G Rolink, M Busslinger.   

Abstract

Despite being one of the most intensively studied cell types, the molecular basis of B cell specification is largely unknown. The Pax5 gene encoding the transcription factor BSAP is required for progression of B-lymphopoiesis beyond the pro-B cell stage. Pax5-deficient pro-B cells are, however, not yet committed to the B-lymphoid lineage, but instead have a broad lymphomyeloid developmental potential. Pax5 appears to mediate B-lineage commitment by repressing the transcription of non-B-lymphoid genes and by simultaneously activating the expression of B-lineage-specific genes. Pax5 thus functions both as a transcriptional repressor and activator, depending on its interactions with corepressors of the Groucho protein family or with positive regulators such as the TATA-binding protein. Once committed to the B-lineage, B cells require Pax5 function to maintain their B-lymphoid identity throughout B cell development.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11342298     DOI: 10.3109/08830180109056723

Source DB:  PubMed          Journal:  Int Rev Immunol        ISSN: 0883-0185            Impact factor:   5.311


  26 in total

Review 1.  The notch pathway: modulation of cell fate decisions in hematopoiesis.

Authors:  K Ohishi; B Varnum-Finney; I D Bernstein
Journal:  Int J Hematol       Date:  2002-06       Impact factor: 2.490

2.  Changes in histone acetylation are associated with differences in accessibility of V(H) gene segments to V-DJ recombination during B-cell ontogeny and development.

Authors:  Kristen Johnson; Cristina Angelin-Duclos; Sinae Park; Kathryn L Calame
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

3.  Patterns of gene divergence and VL promoter activity in immunoglobulin light chain clusters of the channel catfish.

Authors:  Julia Cay Jones; Seyed H Ghaffari; Craig J Lobb
Journal:  Immunogenetics       Date:  2004-09-03       Impact factor: 2.846

4.  The PAX5 gene is frequently rearranged in BCR-ABL1-positive acute lymphoblastic leukemia but is not associated with outcome. A report on behalf of the GIMEMA Acute Leukemia Working Party.

Authors:  Ilaria Iacobucci; Annalisa Lonetti; Francesca Paoloni; Cristina Papayannidis; Anna Ferrari; Clelia Tiziana Storlazzi; Marco Vignetti; Daniela Cilloni; Francesca Messa; Viviana Guadagnuolo; Stefania Paolini; Loredana Elia; Monica Messina; Antonella Vitale; Giovanna Meloni; Simona Soverini; Fabrizio Pane; Michele Baccarani; Robin Foà; Giovanni Martinelli
Journal:  Haematologica       Date:  2010-06-09       Impact factor: 9.941

Review 5.  Contingent gene regulatory networks and B cell fate specification.

Authors:  Harinder Singh; Kay L Medina; Jagan M R Pongubala
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-23       Impact factor: 11.205

6.  CD93 is required for maintenance of antibody secretion and persistence of plasma cells in the bone marrow niche.

Authors:  Stéphane Chevrier; Céline Genton; Axel Kallies; Alexander Karnowski; Luc A Otten; Bernard Malissen; Marie Malissen; Marina Botto; Lynn M Corcoran; Stephen L Nutt; Hans Acha-Orbea
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-19       Impact factor: 11.205

7.  Noncoordinate expression of J-chain and Blimp-1 define nurse shark plasma cell populations during ontogeny.

Authors:  Caitlin D Castro; Yuko Ohta; Helen Dooley; Martin F Flajnik
Journal:  Eur J Immunol       Date:  2013-08-27       Impact factor: 5.532

Review 8.  B cell biology: an overview.

Authors:  Hermann Eibel; Helene Kraus; Heiko Sic; Anne-Kathrin Kienzler; Marta Rizzi
Journal:  Curr Allergy Asthma Rep       Date:  2014-05       Impact factor: 4.806

9.  Enforced expression of EBF in hematopoietic stem cells restricts lymphopoiesis to the B cell lineage.

Authors:  Zheng Zhang; Claudiu V Cotta; Robert P Stephan; Cristina G deGuzman; Christopher A Klug
Journal:  EMBO J       Date:  2003-09-15       Impact factor: 11.598

10.  A tamoxifen inducible knock-in allele for investigation of E2A function.

Authors:  Mary E Jones; Motonari Kondo; Yuan Zhuang
Journal:  BMC Dev Biol       Date:  2009-10-12       Impact factor: 1.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.